https://www.zacks.com/stock/news/2223428/will-telephone-data-systems-tds-report-negative-q4-earnings-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2223428
Feb 08, 2024 - TDS (TDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-3253980863892747263
0
https://seekingalpha.com/article/4671101-telephone-and-data-systems-inc-tds-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Feb 16, 2024 - Telephone and Data Systems, Inc. (NYSE:NYSE:TDS) Q4 2023 Earnings Conference Call February 16, 2024 10:00 AM ETCompany ParticipantsColleen Thompson - VP,...
0
sa:4107356788630365942
0
https://www.zacks.com/stock/news/2227550/telephone-and-data-systems-tds-q4-loss-narrower-than-expected?cid=CS-ZC-FT-analyst_blog|earnings_article-2227550
Feb 16, 2024 - Telephone and Data Systems' (TDS) top line is impeded by declining revenues from the U.S. Cellular vertical. However, growth in TDS Telecom partially reverses this declining trend.
zc:5146405926546650149
0
https://www.zacks.com/stock/news/2227587/compared-to-estimates-tds-tds-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2227587
Feb 16, 2024 - While the top- and bottom-line numbers for TDS (TDS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:440638432405300068
0
https://www.zacks.com/stock/news/2246078/compared-to-estimates-td-synnex-snx-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2246078
Mar 26, 2024 - Although the revenue and EPS for TD SYNNEX (SNX) give a sense of how its business performed in the quarter ended February 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:1889130275208164764
0
https://seekingalpha.com/news/4083718-td-cowen-ups-stoke-to-buy-on-updated-data-for-epilepsy-drug?source=feed_sector_healthcare
Mar 26, 2024 - TD Cowen upgraded Stoke Therapeutics (STOK) to buy based on updated Phase 1/2 data for the company’s epilepsy drug candidate STK-001. Read more here.
0
sa:6773635004851759568
0
https://www.zacks.com/stock/news/2246889/td-bank-td-rolls-out-td-complete-checking-td-early-pay?cid=CS-ZC-FT-analyst_blog|company_news_-_finance_sector-2246889
Mar 27, 2024 - TD Bank's (TD) TD Complete Checking and TD Early Pay offerings are set to offer customers convenience and help the company enhance its deposit balance.
zc:-5397587503412143624
0
https://seekingalpha.com/article/4681247-td-bank-good-time-to-buy-5-percent-yielding-blue-chip-deal?source=feed_all_articles
Mar 29, 2024 - TD Bank's financial position is vigorous enough to earn upper investment-grade credit ratings from the three major rating agencies. Read why I rate TD stock a buy.
0
sa:-7327915231277040651
0
https://seekingalpha.com/news/4089805-td-cowen-says-sickle-cell-therapies-may-get-higher-cms-payments?source=feed_sector_healthcare
Apr 15, 2024 - TD Cowen said recently approved gene therapies by Vertex (VRTX)/CRISPR (CRSP) and bluebird bio (BLUE) may get enhanced payments under proposed CMS guidelines. Read more here.
0
sa:1363788981963750155
0
https://www.zacks.com/stock/news/2260404/bsac-or-td-which-is-the-better-value-stock-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2260404
Apr 23, 2024 - BSAC vs. TD: Which Stock Is the Better Value Option?
zc:-4256287534773767828
0